S Phase, LLC

sphase.com

S Phase, LLC is a medical communications agency working towards improving patient care by delivering medical communication programs that are engaging, accessible and tell a cohesive story across various channels.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Research

STALLERGENES GREER AND APTAR PHARMA ANNOUNCE PARTNERSHIP TO DEVELOP NOVEL CONNECTED DEVICE FOR ALLERGEN IMMUNOTHERAPY TREATMENT DELIVERY

STALLERGENES GREER LTD | October 27, 2021

news image

Stallergenes Greer, a global healthcare company specialising in allergen immunotherapy (AIT), today announced that the company has entered into an exclusive partnership with Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, for the development of the first of its kind connected device and companion mobile app for patients undergoing Stallergenes Greer’s AIT treatments with sublingual solutions. “This exclusive partn...

Read More

Business Insights

PRIME MEDICINE EXPANDS LEADERSHIP TEAM WITH KEY APPOINTMENTS TO SUPPORT CONTINUED GROWTH AND ADVANCEMENT OF PRIME EDITING TECHNOLOGY AND PORTFOLIO

Prime Medicine | July 29, 2022

news image

Prime Medicine, Inc. a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, Prime Editors, to address the widest spectrum of diseases by deploying Prime Editing technology “Prime Medicine is advancing a first-of-its-kind technology intended to expand the number of patients who may benefit from genetic medicines. We are thrilled to welcome Richard, Niamh and Fubao to the team. Together, they bri...

Read More

Business Insights, PHARMACY MARKET

NOVO NORDISK & ATLATL ANNOUNCE WINNERS IN THEIR JOINT PROGRAM ENTRESTAR

Novo Nordisk & ATLATL | December 06, 2022

news image

Novo Nordisk Research Centre China and ATLATL jointly announce the winners of EntreStar program. Hangzhou DNano MetaBio and Modit Medicine stood out among all participants and won the awards. The two winners will be given priority access to one of ATLATL’s nation-wide facilities in China, and a prize of CNY 500K RMB each to pay for the ATLATL facilities and services. They are also entitled to mentoring by relevant experts of Novo Nordisk. There will be no strings attached fo...

Read More

Pharmacy Market

MEDNOW ANNOUNCES PHARMACY PARTNERSHIP AGREEMENT WITH SERVICEPLUS, A NATIONAL TOTAL REWARDS PLATFORM OPERATED BY PIPSC

Businesswire | June 20, 2023

news image

Mednow Inc. Canada’s on-demand virtual pharmacy, is pleased to announce that the Company has executed a Preferred Pharmacy Agreement with ServicePlus, a leading provider of Member Benefit and rewards services. The agreement allows ServicePlus members to leverage enhanced services and preferred pricing from Mednow digital pharmacy and healthcare platform to its clients and plan members. "Mednow is thrilled to partner with ServicePlus to expand access to virtual pharmac...

Read More
news image

Research

STALLERGENES GREER AND APTAR PHARMA ANNOUNCE PARTNERSHIP TO DEVELOP NOVEL CONNECTED DEVICE FOR ALLERGEN IMMUNOTHERAPY TREATMENT DELIVERY

STALLERGENES GREER LTD | October 27, 2021

Stallergenes Greer, a global healthcare company specialising in allergen immunotherapy (AIT), today announced that the company has entered into an exclusive partnership with Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, for the development of the first of its kind connected device and companion mobile app for patients undergoing Stallergenes Greer’s AIT treatments with sublingual solutions. “This exclusive partn...

Read More
news image

Business Insights

PRIME MEDICINE EXPANDS LEADERSHIP TEAM WITH KEY APPOINTMENTS TO SUPPORT CONTINUED GROWTH AND ADVANCEMENT OF PRIME EDITING TECHNOLOGY AND PORTFOLIO

Prime Medicine | July 29, 2022

Prime Medicine, Inc. a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, Prime Editors, to address the widest spectrum of diseases by deploying Prime Editing technology “Prime Medicine is advancing a first-of-its-kind technology intended to expand the number of patients who may benefit from genetic medicines. We are thrilled to welcome Richard, Niamh and Fubao to the team. Together, they bri...

Read More
news image

Business Insights, PHARMACY MARKET

NOVO NORDISK & ATLATL ANNOUNCE WINNERS IN THEIR JOINT PROGRAM ENTRESTAR

Novo Nordisk & ATLATL | December 06, 2022

Novo Nordisk Research Centre China and ATLATL jointly announce the winners of EntreStar program. Hangzhou DNano MetaBio and Modit Medicine stood out among all participants and won the awards. The two winners will be given priority access to one of ATLATL’s nation-wide facilities in China, and a prize of CNY 500K RMB each to pay for the ATLATL facilities and services. They are also entitled to mentoring by relevant experts of Novo Nordisk. There will be no strings attached fo...

Read More
news image

Pharmacy Market

MEDNOW ANNOUNCES PHARMACY PARTNERSHIP AGREEMENT WITH SERVICEPLUS, A NATIONAL TOTAL REWARDS PLATFORM OPERATED BY PIPSC

Businesswire | June 20, 2023

Mednow Inc. Canada’s on-demand virtual pharmacy, is pleased to announce that the Company has executed a Preferred Pharmacy Agreement with ServicePlus, a leading provider of Member Benefit and rewards services. The agreement allows ServicePlus members to leverage enhanced services and preferred pricing from Mednow digital pharmacy and healthcare platform to its clients and plan members. "Mednow is thrilled to partner with ServicePlus to expand access to virtual pharmac...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us